scholarly journals Immunotherapy with rituximab/interleukin 2 (IL-2) following autologous peripheral blood stem cell transplant (ASCT) as treatment for CD20 positive non-hodgkin’s lymphoma

2006 ◽  
Vol 12 (2) ◽  
pp. 116
Author(s):  
L.A. Holmberg ◽  
D. Maloney ◽  
T. Gooley ◽  
W.I. Bensinger
Sign in / Sign up

Export Citation Format

Share Document